Login / Signup

The Safety and Efficacy of the Repeated PRRT with [90Y]Y/[177Lu]Lu-DOTATATE in Patients with NET.

Katarzyna KuśnierzPaweł GutDariusz PawlakMaciej KolodziejLeszek KrólickiBeata Kos-KudlaMarek RuchalaGrzegorz KamińskiJolanta Kunikowska
Published in: International journal of endocrinology (2021)
The repeated therapy with [90Y]Y/[177Lu]Lu-DOTATATE is safe and effective for patients with disseminated, inoperable G1 and G2 neuroendocrine tumours.
Keyphrases
  • pet ct
  • neuroendocrine tumors
  • radiation therapy